首页> 外文期刊>mSphere >Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine
【24h】

Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine

机译:抗生素诱导的肠道菌群改变改变次级胆汁酸的产生,并允许艰难梭菌孢子萌发和大肠生长。

获取原文
           

摘要

It is hypothesized that the depletion of microbial members responsible for converting primary bile acids into secondary bile acids reduces resistance to Clostridium difficile colonization. To date, inhibition of C.?difficile growth by secondary bile acids has only been shown in vitro . Using targeted bile acid metabolomics, we sought to define the physiologically relevant concentrations of primary and secondary bile acids present in the murine small and large intestinal tracts and how these impact C.?difficile dynamics. We treated mice with a variety of antibiotics to create distinct microbial and metabolic (bile acid) environments and directly tested their ability to support or inhibit C.?difficile spore germination and outgrowth ex vivo. Susceptibility to C.?difficile in the large intestine was observed only after specific broad-spectrum antibiotic treatment (cefoperazone, clindamycin, and vancomycin) and was accompanied by a significant loss of secondary bile acids (deoxycholate, lithocholate, ursodeoxycholate, hyodeoxycholate, and ω-muricholate). These changes were correlated to the loss of specific microbiota community members, the Lachnospiraceae and Ruminococcaceae families. Additionally, physiological concentrations of secondary bile acids present during C.?difficile resistance were able to inhibit spore germination and outgrowth in vitro . Interestingly, we observed that C.?difficile spore germination and outgrowth were supported constantly in murine small intestinal content regardless of antibiotic perturbation, suggesting that targeting growth of C.?difficile will prove most important for future therapeutics and that antibiotic-related changes are organ specific. Understanding how the gut microbiota regulates bile acids throughout the intestine will aid the development of future therapies for C.?difficile infection and other metabolically relevant disorders such as obesity and diabetes. IMPORTANCE Antibiotics alter the gastrointestinal microbiota, allowing for Clostridium difficile infection, which is a significant public health problem. Changes in the structure of the gut microbiota alter the metabolome, specifically the production of secondary bile acids. Specific bile acids are able to initiate C.?difficile spore germination and also inhibit C.?difficile growth in vitro , although no study to date has defined physiologically relevant bile acids in the gastrointestinal tract. In this study, we define the bile acids C.?difficile spores encounter in the small and large intestines before and after various antibiotic treatments. Antibiotics that alter the gut microbiota and deplete secondary bile acid production allow C.?difficile colonization, representing a mechanism of colonization resistance. Multiple secondary bile acids in the large intestine were able to inhibit C.?difficile spore germination and growth at physiological concentrations and represent new targets to combat C.?difficile in the large intestine.
机译:据推测,负责将伯胆汁酸转化为仲胆汁酸的微生物成员的减少降低了对艰难梭菌定殖的抗性。迄今为止,仅在体外显示出仲胆汁酸对艰难梭菌生长的抑制作用。我们使用有针对性的胆汁酸代谢组学,试图确定鼠小肠和大肠中存在的伯,仲胆汁酸的生理相关浓度,以及它们如何影响艰难梭菌动力学。我们用各种抗生素处理小鼠,以创建独特的微生物和代谢(胆汁酸)环境,并直接测试了它们支持或抑制艰难梭菌孢子萌发和离体的能力。仅在进行特定的广谱抗生素治疗(头孢哌酮,克林霉素和万古霉素)后,才观察到大肠艰难梭菌的易感性,并伴有大量次生胆汁酸(脱氧胆酸,石胆酸,熊去氧胆酸,猪去氧胆酸和ω)的损失。 -去甲胆酸盐)。这些变化与特定的微生物群落成员,Lachnospiraceae和Ruminococcaceae家族的丧失有关。另外,艰难梭菌抗性过程中存在的生理浓度的仲胆汁酸能够在体外抑制孢子萌发和生长。有趣的是,我们观察到艰难梭菌孢子的萌发和生长在鼠小肠中得到了持续的支持,而不受抗生素干扰的影响,这表明靶向艰难梭菌的生长对于未来的治疗方法将是最重要的,并且与抗生素相关的变化是器官具体。了解肠道菌群如何在整个肠道内调节胆汁酸将有助于未来艰难梭菌感染和其他代谢相关疾病(例如肥胖症和糖尿病)的治疗方法的开发。重要提示抗生素会改变胃肠道微生物群,导致艰难梭菌感染,这是一个重大的公共卫生问题。肠道菌群结构的变化会改变代谢组,特别是次级胆汁酸的产生。特定的胆汁酸能够在体外启动艰难梭菌的孢子萌发并抑制艰难梭菌的生长,尽管迄今为止尚无研究确定胃肠道中与生理相关的胆汁酸。在这项研究中,我们定义了在各种抗生素治疗前后小肠和大肠中遇到的胆汁酸艰难梭菌孢子。改变肠道菌群并耗尽次级胆汁酸产生的抗生素使艰难梭菌得以定殖,这代表了定殖抗性的机制。大肠中的多个仲胆汁酸能够在生理浓度下抑制艰难梭菌孢子的萌发和生长,并且代表了对抗大肠艰难梭菌的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号